Bora Pharmaceuticals
From sites in North America and Asia, Bora delivers drug products with unparalleled quality to our pharmaceutical partners around the globe.
We help drive your drug programs to market success
- At Bora Pharmaceuticals, we see it as our mission, our duty, our responsibility, to make our success and our customer’s success more certain.
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products.
From our world-class sites in North America and Asia, we deliver drug products with unparalleled quality to more than 100 markets around the world. Bora’s teams, technologies, and facilities work seamlessly together to enable our clients to deliver much-needed therapeutics to patients worldwide.
Diverse small molecule drug product manufacturing and packaging capabilities
- Leverage Bora’s premium contract manufacturing offerings for oral solid doses (OSD), semi-solids, liquids, nasal sprays, and ophthalmics using state-of-the-art technologies to get your prescription (Rx) and OTC medicines reliably and faster to patients around the world.
Bora’s global manufacturing footprint
Our worldwide presence and deep regulatory expertise enable partners to meet country-specific commercial and regulatory requirements, ensuring therapies reach patients worldwide in the most efficient way possible.
10
State-of-the-art manufacturing sites
inspected and approved by global regulatory bodies
105,000+ sq. m
Manufacturing space
across our facilities in North America and Asia
$60M+
Invested
in world-class facilities, equipment, and personnel
Bora currently owns and operates nine cGMP manufacturing facilities – in Taiwan, Canada, and the United States – built to the highest international standards for pharmaceutical development, manufacturing, packaging, labeling, and analytical testing.
We manufacture and supply finished drug products to countries in North, Central, and South America, Europe, Russia, the Middle East, and Asia, as well as Australia and New Zealand.
Approved by global regulatory authorities
